reglab/housing_qa huggingface dataset:
CA Health & Safety Code § 132002 (2021)
2021 California Code|Health and Safety Code - HSC|DIVISION 114 - Prescription Drug Discount Prohibition|Section 132002.

132002.  Except as provided in Section 132004, a person who manufactures a prescription drug shall not offer in the state a discount, repayment, product voucher, or other reduction in the individual’s out-of-pocket expenses associated with his or her health insurance, health care service plan, or other health coverage, including, but not limited to, a copayment, coinsurance, or deductible, for a prescription drug if the active ingredients of the drug are contained in products regulated by the federal Food and Drug Administration, are available without prescription at a lower cost, and are not otherwise contraindicated for treatment of the condition for which the prescription drug is approved.(Added by Stats. 2017, Ch. 611, Sec. 1. (AB 265) Effective January 1, 2018.)
CA Health & Safety Code § 132004 (2021)
2021 California Code|Health and Safety Code - HSC|DIVISION 114 - Prescription Drug Discount Prohibition|Section 132004.

132004.  The prohibitions in Sections 132000 and 132002 shall not apply to any of the following:(a) A discount, repayment, product voucher, or other payment to a patient or another person on the patient’s behalf for a prescription drug required under a United States Food and Drug Administration Risk Evaluation and Mitigation Strategy for the purpose of monitoring or facilitating the use of that prescription drug in a manner consistent with the approved labeling of the prescription drug.(b) A single-tablet drug regimen for treatment or prevention of human immunodeficiency virus (HIV) or acquired immune deficiency syndrome (AIDS) that is as effective as a multitablet regimen, unless, consistent with clinical guidelines and peer-reviewed scientific and medical literature, the multitablet regimen is clinically equally effective or more effective and is more likely to result in adherence to the drug regimen.(c) The individual has completed any applicable step therapy or prior authorization requirements for the branded prescription drug as mandated by the individual’s health insurer, health care service plan, or other health coverage.(d) A discount, repayment, product voucher, or other reduction in an individual’s out-of-pocket expenses is not associated with his or her health insurance, health care service plan, or other health coverage.(e) Rebates received by a state agency.(Added by Stats. 2017, Ch. 611, Sec. 1. (AB 265) Effective January 1, 2018.)
CA Health & Safety Code § 132006 (2021)
2021 California Code|Health and Safety Code - HSC|DIVISION 114 - Prescription Drug Discount Prohibition|Section 132006.

132006.  This division does not prohibit an entity, including an entity that manufactures prescription drugs or a patient assistance program that is solely funded by one or more manufacturers, from offering a pharmaceutical product free of any cost, if the product is free of cost to both the patient and his or her health insurer, health care service plan, or other health coverage.(Added by Stats. 2017, Ch. 611, Sec. 1. (AB 265) Effective January 1, 2018.)
CA Health & Safety Code § 132008 (2021)
2021 California Code|Health and Safety Code - HSC|DIVISION 114 - Prescription Drug Discount Prohibition|Section 132008.

132008.  (a) This division shall not be deemed to affect a pharmacist’s ability to substitute a prescription drug pursuant to Section 4073 of the Business and Professions Code.(b) (1) This division shall not prohibit or limit assistance to a patient provided by an independent charity patient assistance program.(2) For purposes of this section, “independent charity patient assistance program” means a program that meets all of the following requirements:(A) The program does not allow a pharmaceutical manufacturer or an affiliate of the manufacturer, including, but not limited to, an employee, agent, officer, shareholder, contractor, wholesaler, distributor, or pharmacy benefits manager, to exert any direct or indirect influence or control over the charity or subsidy program.(B) Assistance is awarded in a truly independent manner that severs any link between a pharmaceutical manufacturer’s funding and the beneficiary.(C) Assistance is awarded without regard to the pharmaceutical manufacturer’s interest and without regard to the beneficiary’s choice of product, provider, practitioner, supplier, health insurance, health care service plan, or other health coverage.(D) Assistance is awarded based upon a reasonable, verifiable, and uniform measure of financial need that is applied in a consistent manner.(E) The pharmaceutical manufacturer does not solicit or receive data from the program that would facilitate the manufacturer in correlating the amount or frequency of its donations with the number of subsidized prescriptions for its products.(Added by Stats. 2017, Ch. 611, Sec. 1. (AB 265) Effective January 1, 2018.)
CA Health & Safety Code § 150200 (2021)
2021 California Code|Health and Safety Code - HSC|DIVISION 116 - SURPLUS MEDICATION COLLECTION AND DISTRIBUTION|Section 150200.

150200.  It is the intent of the Legislature in enacting this division to authorize the establishment of a voluntary drug repository and distribution program for the purpose of distributing surplus medications to persons in need of financial assistance to ensure access to necessary pharmaceutical therapies. It is also the intent of the Legislature that the health and safety of Californians are protected and promoted through this program, while reducing unnecessary waste at licensed health and care facilities, by allowing those facilities to donate unused and unexpired medications that were never in the hands of a patient or resident and for which no credit or refund to the patient or resident could be received.(Amended by Stats. 2012, Ch. 709, Sec. 1. (SB 1329) Effective January 1, 2013.)
CA Health & Safety Code § 150201 (2021)
2021 California Code|Health and Safety Code - HSC|DIVISION 116 - SURPLUS MEDICATION COLLECTION AND DISTRIBUTION|Section 150201.

150201.  For purposes of this division:(a) “Donor organization” means an entity described in subdivision (a) of Section 150202.(b) “Eligible entity” means all of the following:(1) A licensed pharmacy, as defined in subdivision (a) of Section 4037 of the Business and Professions Code, that is county owned or that contracts with the county pursuant to this division and is not on probation with the California State Board of Pharmacy.(2) A licensed pharmacy, as defined in subdivision (a) of Section 4037 of the Business and Professions Code, that is owned and operated by a primary care clinic, as defined in Section 1204, that is licensed by the State Department of Public Health and is not on probation with the California State Board of Pharmacy.(3) A primary care clinic, as defined in Section 1204, that is licensed by the State Department of Public Health and licensed to administer and dispense drugs pursuant to subparagraph (A) of paragraph (1) of subdivision (a) of Section 4180 of the Business and Professions Code and is not on probation with the California State Board of Pharmacy.(c) “Medication” or “medications” means a dangerous drug, as defined in Section 4022 of the Business and Professions Code.(d) “Participating entity” means an eligible entity that has received written or electronic documentation from the county health department pursuant to paragraph (3) of subdivision (a) of Section 150204 and that operates a repository and distribution program pursuant to this division.(Amended by Stats. 2014, Ch. 10, Sec. 3. (AB 467) Effective April 9, 2014.)
CA Health & Safety Code § 150202 (2021)
2021 California Code|Health and Safety Code - HSC|DIVISION 116 - SURPLUS MEDICATION COLLECTION AND DISTRIBUTION|Section 150202.

150202.  (a) Notwithstanding any other law, a donor organization is defined, for purposes of this division, to refer to one of the following health and care facilities that may donate centrally stored unused medications under a program established pursuant to this division:(1) A licensed general acute care hospital, as defined in Section 1250.(2) A licensed acute psychiatric hospital, as defined in Section 1250.(3) A licensed skilled nursing facility, as defined in Section 1250, including a skilled nursing facility designated as an institution for mental disease.(4) A licensed intermediate care facility, as defined in Section 1250.(5) A licensed intermediate care facility/developmentally disabled-habilitative facility, as defined in Section 1250.(6) A licensed intermediate care facility/developmentally disabled-nursing facility, as defined in Section 1250.(7) A licensed correctional treatment center, as defined in Section 1250.(8) A licensed psychiatric health facility, as defined in Section 1250.2.(9) A licensed chemical dependency recovery hospital, as defined in Section 1250.3.(10) A licensed residential care facility for the elderly, as defined in Section 1569.2, with 16 or more residents.(11) An approved mental health rehabilitation center, as described in Section 5675 of the Welfare and Institutions Code.(b) Medication donated by health and care facilities pursuant to subdivision (a) shall meet the requirements of subdivisions (c) and (d) of Section 150204 and shall be unexpired medication that would have otherwise been destroyed by the facility or another appropriate entity.(c) Medication eligible for donation by the health and care facilities pursuant to subdivision (a) shall be directly delivered from the dispensing pharmacy, wholesaler or manufacturer, to the health or care facility and subsequently centrally stored. Centrally stored medication that originated from a patient or resident is not eligible for donation under this division.(Amended by Stats. 2014, Ch. 10, Sec. 4. (AB 467) Effective April 9, 2014.)
CA Health & Safety Code § 150202.5 (2021)
2021 California Code|Health and Safety Code - HSC|DIVISION 116 - SURPLUS MEDICATION COLLECTION AND DISTRIBUTION|Section 150202.5.

150202.5.  Notwithstanding any other law, a pharmacy, licensed in California and not on probation with the California State Board of Pharmacy, whose primary or sole type of pharmacy practice type is limited to a skilled nursing facility, home health care, board and care, or mail order, may donate unused, unexpired medication that meets the requirements of subdivisions (c) and (d) of Section 150204, under a program established pursuant to this division and that meets either of the following requirements:(a) The medication was received directly from a manufacturer or wholesaler.(b) The medication was returned from a health facility to the issuing pharmacy, in a manner consistent with state and federal law. (Added by Stats. 2012, Ch. 709, Sec. 4. (SB 1329) Effective January 1, 2013.)
CA Health & Safety Code § 150203 (2021)
2021 California Code|Health and Safety Code - HSC|DIVISION 116 - SURPLUS MEDICATION COLLECTION AND DISTRIBUTION|Section 150203.

150203.  Notwithstanding any other provision of law, a wholesaler licensed pursuant to Article 11 (commencing with Section 4160) of Chapter 9 of Division 2 of the Business and Professions Code and a drug manufacturer that is legally authorized under federal law to manufacture and sell pharmaceutical drugs may donate unused medications under the voluntary drug repository and distribution program established by a county pursuant to this division.(Added by Stats. 2005, Ch. 444, Sec. 1. Effective January 1, 2006.)
CA Health & Safety Code § 150205 (2021)
2021 California Code|Health and Safety Code - HSC|DIVISION 116 - SURPLUS MEDICATION COLLECTION AND DISTRIBUTION|Section 150205.

150205.  (a) The following persons and entities shall not be subject to criminal or civil liability for injury caused when donating, accepting, or dispensing prescription drugs in compliance with this division:(1) A prescription drug manufacturer, wholesaler, governmental entity, or participating entity.(2) A pharmacist or physician who accepts or dispenses prescription drugs.(3) A licensed health or care facility, as described in Section 150202, or a pharmacy, as described in Section 150202.5.(b) A surplus medication collection and distribution intermediary, as described in Section 150208, shall not be subject to criminal or civil liability for injury caused when facilitating the donation of medications to or transfer of medications in compliance with this division.(Amended by Stats. 2014, Ch. 10, Sec. 5. (AB 467) Effective April 9, 2014.)
CA Health & Safety Code § 150206 (2021)
2021 California Code|Health and Safety Code - HSC|DIVISION 116 - SURPLUS MEDICATION COLLECTION AND DISTRIBUTION|Section 150206.

150206.  The immunities provided in Section 150205 shall not apply in cases of noncompliance with this division, bad faith, or gross negligence.(Added by Stats. 2005, Ch. 444, Sec. 1. Effective January 1, 2006.)
CA Health & Safety Code § 150207 (2021)
2021 California Code|Health and Safety Code - HSC|DIVISION 116 - SURPLUS MEDICATION COLLECTION AND DISTRIBUTION|Section 150207.

150207.  Nothing in this division shall affect disciplinary actions taken by licensing and regulatory agencies.(Added by Stats. 2005, Ch. 444, Sec. 1. Effective January 1, 2006.)
CA Health & Safety Code § 150208 (2021)
2021 California Code|Health and Safety Code - HSC|DIVISION 116 - SURPLUS MEDICATION COLLECTION AND DISTRIBUTION|Section 150208.

150208.  (a) A surplus medication collection and distribution intermediary that is licensed pursuant to Section 4169.5 of the Business and Professions Code, established for the purpose of facilitating the donation of medications to or transfer of medications between participating entities under a program established pursuant to this division is authorized to operate under this section.(b) A surplus medication collection and distribution intermediary shall comply with the following:(1) It shall not take possession, custody, or control of dangerous drugs and devices.(2) It shall ensure that notification is provided to participating entities that a package has been shipped when the surplus medication collection and distribution intermediary has knowledge of the shipment and provided logistical support to facilitate a shipment directly from a donor organization, as defined in subdivision (a) of Section 150202, to a participating entity.(3) It shall not select, or direct a donor organization, as defined in subdivision (a) of Section 150202, to select, a specific participating entity to receive surplus medications.(c) A surplus medication collection and distribution intermediary is authorized to do the following:(1) Charge membership, administrative, or overhead fees sufficient to cover the reasonable costs of the support and services provided.(2) Contract directly with a county to facilitate the donation of medications to or transfer of medications between participating entities and provide general support in a county’s implementation of a program established pursuant to this division.(d) No participating entities shall receive donated medication directly from the surplus medication collection and distribution intermediary. (Added by Stats. 2014, Ch. 10, Sec. 6. (AB 467) Effective April 9, 2014.)
CA Health & Safety Code § 150400 (2021)
2021 California Code|Health and Safety Code - HSC|DIVISION 117 - Cancer Medication Recycling Act|Section 150400.

150400.  This division shall be known, and may be cited, as the Cancer Medication Recycling Act.(Added by Stats. 2021, Ch. 541, Sec. 2. (SB 310) Effective January 1, 2022. Repealed as of January 1, 2027, pursuant to Section 150404.)
CA Health & Safety Code § 150401 (2021)
2021 California Code|Health and Safety Code - HSC|DIVISION 117 - Cancer Medication Recycling Act|Section 150401.

150401.  For purposes of this division, the following definitions apply:(a) “Donor” means an individual who donates unused prescription drugs to a participating practitioner for the purpose of redistribution to established patients of that practitioner.(b) “Ineligible drugs” means drugs that are not able to be accepted for redistribution as part of the program established pursuant to this division. “Ineligible drugs” include all controlled substances, including all opioids, all compounded medications, injectable medications, drugs that have an approved United States Food and Drug Administration Risk Evaluation and Mitigation Strategy (REMS) requirement, and all growth factor medications.(c) “Participating practitioner” means a person who is licensed to practice medicine by the Medical Board of California and is board certified in medical oncology or hematology and is registered with a surplus medication collection and distribution intermediary.(d) “Recipient” means an individual who voluntarily receives donated prescription medications.(e) “Surplus medication collection and distribution intermediary” means an entity licensed pursuant to Section 4169.5 of the Business and Professions Code as a surplus medication collection and distribution intermediary, as described in Section 150208.(f) “Unused cancer medication” or “medication” means a medication or drug, including a “dangerous drug” as defined in Section 4022 of the Business and Professions Code or a “drug” as defined in Section 4025 of the Business and Professions Code, that is prescribed as part of a cancer treatment plan and is in its original container or packaging.(Added by Stats. 2021, Ch. 541, Sec. 2. (SB 310) Effective January 1, 2022. Repealed as of January 1, 2027, pursuant to Section 150404.)
CA Health & Safety Code § 150402 (2021)
2021 California Code|Health and Safety Code - HSC|DIVISION 117 - Cancer Medication Recycling Act|Section 150402.

150402.  An unused cancer medication that is not an ineligible drug as defined in subdivision (b) of Section 150401 may be donated to a participating practitioner, and a participating practitioner may accept and redistribute the donated prescription drugs.(Added by Stats. 2021, Ch. 541, Sec. 2. (SB 310) Effective January 1, 2022. Repealed as of January 1, 2027, pursuant to Section 150404.)
CA Health & Safety Code § 150404 (2021)
2021 California Code|Health and Safety Code - HSC|DIVISION 117 - Cancer Medication Recycling Act|Section 150404.

150404.  This division shall remain in effect only until January 1, 2027, and as of that date is repealed.(Added by Stats. 2021, Ch. 541, Sec. 2. (SB 310) Effective January 1, 2022. Repealed as of January 1, 2027, by its own provisions. Note: Repeal affects Division 117, commencing with Section 150400.)
CA Health & Safety Code § 151000 (2021)
2021 California Code|Health and Safety Code - HSC|DIVISION 120 - SEXUAL HEALTH EDUCATION ACCOUNTABILITY ACT|Section 151000.

151000.  This division shall be known, and may be cited, as the Sexual Health Education Accountability Act.(Added by Stats. 2007, Ch. 602, Sec. 1. Effective January 1, 2008.)
CA Health & Safety Code § 151001 (2021)
2021 California Code|Health and Safety Code - HSC|DIVISION 120 - SEXUAL HEALTH EDUCATION ACCOUNTABILITY ACT|Section 151001.

151001.  For purposes of this division, the following definitions shall apply:(a) “Age appropriate” means topics, messages, and teaching methods suitable to particular ages or age groups of children and adolescents, based on developing cognitive, emotional, and behavioral capacity typical for the age or age group.(b) A “sexual health education program” means a program that provides instruction or information to prevent adolescent pregnancy, unintended pregnancy, or sexually transmitted diseases, including HIV, that is conducted, operated, or administered by any state agency, is funded directly or indirectly by the state, or receives any financial assistance from state funds or funds administered by a state agency, but does not include any program offered by a school district, a county superintendent of schools, or a community college district.(c) “Medically accurate” means verified or supported by research conducted in compliance with scientific methods and published in peer review journals, when appropriate, and recognized as accurate and objective by professional organizations and agencies with expertise in the relevant field, including, but not limited to, the federal Centers for Disease Control and Prevention, the American Public Health Association, the Society for Adolescent Health and Medicine, the American Academy of Family Physicians, the American Academy of Pediatrics, and the American College of Obstetricians and Gynecologists.(Amended by Stats. 2019, Ch. 632, Sec. 12. (AB 1622) Effective January 1, 2020.)
CA Health & Safety Code § 151003 (2021)
2021 California Code|Health and Safety Code - HSC|DIVISION 120 - SEXUAL HEALTH EDUCATION ACCOUNTABILITY ACT|Section 151003.

151003.  This division shall apply only to grants that are funded pursuant to contracts entered into or amended on or after January 1, 2008.(Added by Stats. 2007, Ch. 602, Sec. 1. Effective January 1, 2008.)
CA Ins Code § 1 (2021)
2021 California Code|Insurance Code - INS|GENERAL PROVISIONS|Section 1.

1.  This act shall be known as the Insurance Code.(Enacted by Stats. 1935, Ch. 145.)
CA Ins Code § 2 (2021)
2021 California Code|Insurance Code - INS|GENERAL PROVISIONS|Section 2.

2.  The provisions of this code in so far as they are substantially the same as existing statutory provisions relating to the same subject matter shall be construed as restatements and continuations thereof, and not as new enactments.(Enacted by Stats. 1935, Ch. 145.)
CA Ins Code § 3 (2021)
2021 California Code|Insurance Code - INS|GENERAL PROVISIONS|Section 3.

3.  All persons who, at the time this code goes into effect, hold office under any of the acts repealed by this code, which offices are continued by this code, continue to hold the same according to the former tenure thereof.(Enacted by Stats. 1935, Ch. 145.)
CA Ins Code § 4 (2021)
2021 California Code|Insurance Code - INS|GENERAL PROVISIONS|Section 4.

4.  No action or proceeding commenced before this code takes effect, and no right accrued, is affected by the provisions of this code, but all procedure thereafter taken therein shall conform to the provisions of this code so far as possible.(Enacted by Stats. 1935, Ch. 145.)
CA Ins Code § 5 (2021)
2021 California Code|Insurance Code - INS|GENERAL PROVISIONS|Section 5.

5.  Unless the context otherwise requires, the general provisions hereinafter set forth shall govern the construction of this code.(Enacted by Stats. 1935, Ch. 145.)
CA Ins Code § 6 (2021)
2021 California Code|Insurance Code - INS|GENERAL PROVISIONS|Section 6.

6.  Division, part, chapter, article, and section headings contained herein shall not be deemed to govern, limit, modify or in any manner affect the scope, meaning, or intent of the provisions of any division, part, chapter, article, or section hereof.(Enacted by Stats. 1935, Ch. 145.)
CA Ins Code § 7 (2021)
2021 California Code|Insurance Code - INS|GENERAL PROVISIONS|Section 7.

7.  Whenever, by the provisions of this code, a power is granted to a public officer or a duty imposed upon such an officer, the power may be exercised or the duty performed by a deputy of the officer or by a person authorized pursuant to law by the officer, unless it is expressly otherwise provided.(Enacted by Stats. 1935, Ch. 145.)
CA Ins Code § 8 (2021)
2021 California Code|Insurance Code - INS|GENERAL PROVISIONS|Section 8.

8.  Writing includes any form of recorded message capable of comprehension by ordinary visual means. Whenever any notice, report, statement or record is required or authorized by this code, it shall be made in writing in the English language unless it is otherwise expressly provided.(Enacted by Stats. 1935, Ch. 145.)
CA Ins Code § 9 (2021)
2021 California Code|Insurance Code - INS|GENERAL PROVISIONS|Section 9.

9.  Whenever any reference is made to any portion of this code or of any other law of this State, such reference shall apply to all amendments and additions thereto now or hereafter made.(Enacted by Stats. 1935, Ch. 145.)